九芝堂 (000989)

JIUZHITANG CO.,LTD

ASZ

Tags

Plant-Based MeatImmunotherapyMedical Aesthetics ConceptControl ChangeDelisting Warning RemovalMargin Trading and Securities LendingHigh-Dividend StocksShenzhen ConnectChinese Med. IICSI 2000 IndexSZSE Medicine Equal Weight IndexShenzhen A-Share Pharmaceutical IndexCSI All-share Pharmaceutical Sector IndexSZSE 700 IndexSZSE 1000 IndexSZSE Performance IndexSpin-off Listing ExpectationHepatitis B VaccinePrivate PlacementFTSE Russell ConceptSZSE Selected IndexCNI 2000 IndexSME Board Innovation IndexNew IndexEmerging Industries Composite IndexManufacturing IndexCS Pharmaceutical TI IndexCSI 1000 IndexPrivate Enterprise Development IndexHigh Dividend Yield Strategy IndexPharmaceutical 50 Strategy IndexCICC 300 IndexSZSE Dividend 50 IndexCSI 1000 Value IndexCSI 1000 Value Stable IndexHunan

K-Line Chart

No K-line data available

Company NameJiuzhitang Co., Ltd.
Listing Date2000-06-28
Issue Price9RMB
Registered Capital85594.201210k RMB
Legal RepresentativeSun Guangyuan
Registered AddressNo. 339 Tongzipo West Road, High-tech Zone, Changsha City, Hunan Province
IndustryTraditional Chinese Medicine II
Main BusinessProduction and sales of pharmaceuticals; sales of medical devices and non-staple food; sales of chemical reagents permitted by policy; provision of product packaging printing and pharmaceutical technology consulting services; provision of health consulting services; pharmaceutical technology development; pharmaceutical industry investment.
Company ProfileThe company is a national key traditional Chinese medicine enterprise, a national key high-tech enterprise, a domestic A-share listed company, a Hunan Provincial Quality Management Award enterprise, and a national postdoctoral research workstation. It is one of the few enterprises in China that simultaneously holds the titles of 'China Well-known Trademark', 'China Time-honored Brand', and 'National Intangible Cultural Heritage', and has been selected for four consecutive years among China's Top 500 Most Valuable Brands. It possesses multiple scientific and technological platforms, including the National (Chinese Herbal Pieces) Enterprise Technology Center, National Innovation Pilot Enterprise, Key Discipline Construction Unit of the National Administration of Traditional Chinese Medicine, Hunan Engineering Research Center for Traditional Chinese Medicine Prescriptions, and one of Changsha's first batch of Academician Expert Workstations.

Stock Details

1. Key Indicators

  • Total Shares(W): 85594.20
  • Circulating A-Shares(W): 69415.38
  • Earnings Per Share(RMB): 0.1791
  • Net Assets Per Share(RMB): 4.2651
  • Operating Revenue(W RMB): 162745.33
  • Total Profit(W RMB): 20936.88
  • Net Profit Attributable to Parent(W RMB): 15153.16
  • Net Profit Growth Rate(%): -36.94
  • Weighted Return on Equity(%): 4.1100
  • Operating Cash Flow Per Share(RMB): 0.3630
  • Undistributed Profit Per Share(RMB): 1.0217
  • Capital Reserve Per Share(RMB): 1.8091

2. Main Business

The main business covers:

  • Research, development, production and sales of traditional Chinese medicine

3. Company Basic Information

  • Company Name: Jiuzhitang Co., Ltd.
  • Listing Date: 2000-06-28
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 339 Tongzipo West Road, Changsha City, Hunan Province
  • Website: www.hnjzt.com
  • Company Profile: The company was established in May 1999 as a joint-stock company by five promoters including Changsha Jiuzhitang (Group) Co., Ltd., SDIC Pharmaceutical Investment Co., Ltd., Hainan Xiangyuan Economic and Trade Company, Hunan Pharmaceutical Company, and Hunan Changsha Friendship (Group) Co., Ltd. Among them, Changsha Jiuzhitang (Group) Co., Ltd. contributed net assets and equity, converted into 78.12 million state shares; the other four promoters contributed cash, totaling 10.5 million legal person shares. As of December 31, 1999, the company's total share capital was 88.62 million shares. After the public issuance of 40 million RMB ordinary shares on June 9 and 10, 2000, the company's total share capital reached 128.62 million shares.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Heilongjiang Cheneng Gongda Venture Capital Co., Ltd. General Legal Person 20573.06 29.64
2 ICBC Credit Suisse Frontier Medical Equity Securities Investment Fund A Fund 400.00 0.58
3 Hong Kong Securities Clearing Company Ltd. Northbound Funds 235.73 0.34
4 ICBC Credit Suisse Pharmaceutical Health Industry Equity Securities Investment Fund A Fund 186.93 0.27
5 Yimin Innovation Advantage Hybrid Securities Investment Fund Fund 51.54 0.07

5. Concept Sectors

  • Immunotherapy
  • Medical Aesthetics Concept
  • Innovative Drugs
  • Delisting Risk Removed
  • High Dividend Stocks
  • Control Change

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information